Summary and Conclusion
Despite lingering controversy,it is evident from a detailed review of the literature that human mononuclear phagocytes can be stimulated by various means both in vitro and in vivo to express NOS2 and produce NO.It is difficult to quantitatively compare levels of NO production and NOS2 expression by human and murine mononuclear phagocytes.However,based on several studies in which both murine and human cells have been examined in parallel under identical conditions,human cells appear to produce less NO and express lower levels of NOS2 than do murine cells.This might help to explain the innate resistance of mice to certain human pathogens (e.g.,Mycobacterium tuberculosis).Despite the apparent species differences,it is very likely that human mononuclear phagocyte-generated NO is important in certain pathological states (e.g.,in resistance to infection and mediation of inflammation),and possibly under normal physiological conditions as well.Pharmacological modulation of mononuclear phagocyte NO production should prove to be a useful therapeutic option in some disease states.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Albina, J. E., 1995, On the expression of nitric oxide synthase by human macrophages—why no NO? J. Leukoc. Biol. 58:643–649.
Ambs, S., Merriam, W. G., Bennett, W. P., Felleybosco, E., Ogunfusika, M. O., Oser, S. M., Klein, S., Shields, P. G., Billiar, T. R., and Harris, C. C., 1998, Frequent nitric oxide synthase-2 expression in human colon adenomas—implication for tumor angiogenesis and colon cancer progression, Cancer Res. 58:334–341.
Amin, A. R., Attur, M., Vyas, P., Leszczynska-Piziak, J., Levartovsky, D., Rediske, J., Clancy, R. M., Vora, K. A., and Abramson, S.B.,1997, Expression of nitric oxide synthase in human peripheral blood mononuclear cells and neutrophils, J.Inflamm. 47:190–205.
Anstey, N. M., Weinberg, J. B., Hassanali, M., Mwaikambo, E. D., Manyenga, D., Misukonis, M. A., Arnelle, D. R., Hollis, D., McDonald, M. I., and Granger, D. L, 1996, Nitric oxide in Tanzanian children with malaria. Inverse relationship between malaria severity and nitric oxide production/nitric oxide synthase type 2 expression, J. Exp. Med. 184:557–567.
Aubry, J. P., Dugas, N., Lecoanet-Henchoz, S., Ouaaz, F., Zhao, H. X., Delfraissy, J. F., Graber, P., Kolb, J. P., Dugas, B., and Bonnefoy, J. Y., 1997, The 25-kDa soluble CD23 activates type III constitutive nitric oxide-synthase activity via CD11b and CD 11c expressed by human monocytes, J. Immunol. 159:614–622.
Auwerx, J., 1991, The human leukemia cell line, THP-1: A multifaceted model for the study of monocyte-macrophage differentiation, Experientia (Basel) 47:22–31.
Bagasra, O., Bobroski, F., Sarker, A., Bagasra, A., Saikumari, P., and Pomerantz, R. J., 1997, Absence of the inducible form of nitric oxide synthase in the brains of patients with the acquired immunodeficiency syndrome, J. Neurovirology 3:153–167.
Bagasra, O., Michaels, F. H., Zheng, Y. M., Bobroski, L. E., Spitsin, S. V., Fu, Z. F., Tawadros, R., and Koprowski, H., 1995, Activation of the inducible form of nitric oxide synthase in the brains of patients with multiple sclerosis, Proc. Natl.Acad. Sci.USA 92:12041 12045.
Barnewall, R. E., and Rikihisa, Y., 1994, Abrogation of gamma interferon-induced inhibition of Ehrlichia chaffeensis infection in human monocytcs with iron-transferrin, Infect. Immun. 62:4804–4810
Beckman, J. S., Chen, J., Ischiropoulos, H., and Crow, J.P., 1994a, Oxidative chemistry of peroxynitrite, Methods Enzymol. 233:229–240.
Beckman, J. S., Ye, Y. Z., Anderson, P. G., Chen, J., Accavitti, M. A., Tarpey, M. M., and White, C. R., 1994b, Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohis-tochemistry. Biol. Chem. Hoppe-Seyler 375:81–88.
Belenky, S. N., Robbins, R. A., and Rubinstein, I., 1993, Nitric oxide synthase inhibitors attenuate human monocyte chemotaxis in vitro, J. Leukoc. Biol. 53:498–503.
Ben-Efraim, S., Tak, C., Fieren, M. J. W. A., Romijn, J. C., Beckmahn, I., and Bonta, I. L., 1993, Activity of human peritoneal macrophages against a human tumor: Role of tumor necrosis factor-ℑ PGL2 and nitrite, in vitro studies, Immunol. Lett. 37:27–33.
Bermudez, L. E., 1993, Differential mechanisms of intracellular killing of Mycobacterium avium and Listeria monocytogenes by activated human and murine macrophages. The role of nitric oxide, Clin. Exp. Immunol. 91:277–281.
Bo, L., Dawson, T. M., Wesselingh, S.., Mork, S., Choi, S., Kong, P. A., Hanley, D., and Trapp, B. D., 1994, Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains, Ann Neurol. 36:778–786.
Bose, M., and Farnia, P., 1995, Proinflammatory cytokines can significantly induce human mononuclear phagocytes to produce nitric oxide by a cell maturation-dependent process, Immunol. Lett. 48:59–64.
Bredt, D. S., and Snyder, S. H., 1994, Nitric oxide: A physiologic messenger molecule, Annu. Rev. Biochem. 63:175–195.
Bukrinsky, M. I., Nottet, H., Schmidtmayerova, H., Dubrovsky, L., Flanagan, C. R., Mullins, M. E., Lipton, S. A., and Gendelman, H. E., 1995, Regulation of nitric oxide synthase activity in human immunodeficiency virus type I (HIV-1)-infected monocytes—Implications for HIV-associated neurological disease, J. Exp. Med. 181:735–745.
Buttery, L. D. K., Springall, D. R., Chester, A. H., Evans, T. J., Standfield, N., Parums, D. V., Yacoub, M. H., and Polak, J. M., 1996, Inducible nitric oxide synthase is present within human atherosclerotic lesions and promotes the formation and activity of peroxynitrite, Lab Invest. 75:77–85.
Cameron, M. L., Granger, D. L., Weinberg, J. B., Kozumbo, W. J., and Koren, H. S., 1990, Human alveolar and peritoneal macrophages mediate fungistasis independently of L-arginine oxidation to nitrite or nitrate, Am. Rev. Respir. Dis. 142:1313–1319.
Chen, F., Kuhn, D. C., Gaydos, L. J., and Demers, L. M., 1996, Induction of nitric oxide and nitric oxide synthase mRNA by silica and lipopolysaccharide in PMA-primed THP-1 cells, APMIS 104:176–182.
Chen, L. Y., and Metha, J. L., 1996, Further evidence of the presence of constitutive and inducible nitric oxide synthase isoforms in human platelets, J. Cardiovasc. Pharmacol. 27:154–158.
Chu, S. C., Wu, H. P., Banks, T. C., Eissa, N. T., and Moss, J., 1995, Structural diversity in the 5′-untranslated region of cytokine-stimulated human inducible nitric oxide synthase mRNA, J. Biol. Chem. 270:10625–10630.
Clancy, R. M., and Abramson. S. B., 1995, Nitric oxide—A novel mediator of inflammation, Proc. Soc. Exp. Biol. Med. 210:93–101.
Cobbs, C. S., Brenman, J. E., Aldape, K. D., Bredt, D. S., and Israel, M. A., 1995, Expression of nitric oxide synthase in human central nervous system tumors, Cancer Res. 55:727–730.
Collins, S. J., 1987, The HL-60 promyelocytic leukemia cell line: Proliferation, differentiation, and cellular oncogene expression, Blood 70:1233–1244.
Condino-Neto, A., Muscara, M. N., Grumach, A. S., Carneiro-Sampaio, M. M., and DeNucci, G., 1993, Neutrophils and mononuclear cells from patients with chronic granulomatous disease release nitric oxide, Br. J. Clin. Pharmacol 35:485–490.
Condino-Neto, A., Muscara, M. N., Bellinatipires, R., Carneiro-Sampaio, M. M. S., Brandao, A. C., Grumach, A. S., and DeNucci, G., 1996, Effect of therapy with recombinant human interferon-gamma on the release of nitric oxide by neutrophils and mononuclear cells from patients with chronic granulomatous disease, J. Interferon Cytokine Res. 16:357–364.
Criado-Jimenez, M., Rivas-Cabanero, L., Martin-Oterino, J. A., Lopez-Novoa, J. M., and Sanchez-Rodriguez, A., 1995, Nitric oxide production by mononuclear leukocytes in alcoholic cirrhosis, J. Mol. Med. 73:31–33.
DeGroot, C. J. A., Ruuls, S. R., Theeuwes, J. W. M., Dijkstra, C. D., and Vandervalk, P., 1997, Immunocytochemical characterization of the expression of inducible and constitutive isoforms of nitric oxide synthase in demyelinating multiple sclerosis lesions, J. Neuropathol. Exp. Neurol. 56:10–20.
DeMaria, R., Cifone, M. G., Trotta, R., Rippo, M. R., Festuccia, C., Santoni, A., and Testi, R., 1994, Triggering of human monocyte activation through CD69, a member of the natural killer cell gene complex family of signal transducing receptors, J. Exp. Med. 180:1999–2004.
Denis, M., 1991, Tumor necrosis factor and granulocyte macrophage-colony stimulating factor stimulate human macrophages to restrict growth of virulent Mycobacterium avium and to kill avirulent M. avium: Killing effector mechanism depends on the generation of reactive nitrogen intermediates, J. Leukoc. Biol. 49:380–387.
Denis, M.,1994, Human monocytes/macrophages: NO or no NO? J. Leukoc. Biol. 55:682–684.
Dias-Da-Motta, P., Arruda, V. R., Muscara, M. N., Saad, S. T., DeNucci, G., Costa, F. F., and Condinoneto, A., 1996, The release of nitric oxide and superoxide anion by neutrophils and mononuclear cells from patients with sickle cell anaemia, Br. J. Haematol. 93:333–340.
Ding, A. H., Nathan, C. F., and Stuehr, D. J., 1988, Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production, J. Immunol. 141:2407–2412.
Dugas, N., Vouldoukis, I., Becherel, P., Arock, M., Debre, P., Tardieu, M., Mossalayi, D. M., Delfraissy, J. F., Kolb, J. P., and Dugas, B., 1996, Triggering of CD23b antigen by anti-CD23 monoclonal antibodies induces interleukin-10 production by human macrophages, Eur. J. Inmmunol. 26:1394–1398.
Dumarey, C. H., Labrousse, V, Rastogi, N., Vargaftig, B. B., and Bachelet, M., 1994, Selective Mycobacterium aviuminducedproduction of nitric oxide by human monocyte-derived macrophages, J. Leukoc. Biol. 56:36–40.
Eis, A. L. W., Brockman, D. E., and Myatt, L., 1997, Immunolocalization of the inducible nitric oxide synthase isoform in human fetal membranes, Am. J. Reprod. Immunol. 38:289–294.
Eiserich, J. P., Hristova, M., Cross, C. E., Jones, A. D., Freeman, B. A., Halliwell, B., and van der Vliet, A., 1998, Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils, Nature 391:393–397.
Eissa, N. T, Strauss, A. J., Haggerty, C. M., Choo, E. K., Chu, S. C., and Moss, J., 1996, Alternative splicing of human inducible nitric-oxide synthase mRNA. Tissue-specific regulation and induction by cytokines, J. Biol. Chem. 271:27184–27187.
Essery, S. D., Saadi, A. T., Twite, S. J., Weir, D. M., Blackwell, C. C., and Busuttil A., 1994, Lewis antigen expression on human monocytes and binding of pyrogenic toxins, Agents Actions 41:108–110.
Eue, I., Zeisig, R., and Arndt, D., 1995, Alkylphosphocholine-induced production of nitric oxide and tumor necrosis factor alpha by U937 cells, J. Cancer Res. Clin. Oncol. 121:350–356.
Feelisch, M., and Stamler, J. S., 1996, Methods in Nitric Oxide Research, Wiley, New York.
Goto, H., Nakamura, T., Shirabe, S., Ueki, Y., Nishiura, Y., Furuya, T., Tsujino, A., Nakane, S., Eguchi, K., and Nagataki, S., 1997, Up-regulation of NOS2 mRNA expression and increased production of NO in human monoblast cell line U937 transfected by HTLV-I tax gene, Immunobiology 197:513–521.
Grabowski, P. S., Wright, P. K., Vanthof, R. J., Helfrich, M. H., Ohshima, H., and Ralston, S. H., 1997, Immunolocalization of inducible nitric oxide synthase in synovium and cartilage in rheumatoid arthritis and osteoarthritis, Br. J. Rheumatol. 36:651–655.
Granger, D. L., Hibbs, J. B., Jr., Perfect, J. R., and Durack, D. T., 1988, Specific amino acid (L-arginine) requirement for the microbiostatic activity of murine macrophages, J. Clin. Invest. 81:1129–1136.
Granger, D. L., Taintor, R. R., Boockvar, K. S., and Hibbs, J. B., Jr., 1995, Determination of nitrate and nitrite in biological samples using bacterial nitrate reductase coupled with the Griess reaction, Methods. A Companion to Methods in Enzymology 7:78–83.
Green, L. C., de Luzuriaga, K. R., Wagner, D. A., Rand, W., Istfan, N., Young, V. R., and Tannenbaum, S. R., 1981, Nitrate biosynthesis in man, Proc. Natl. Acad. in.USA 78:7764–7768.
Green, L. C., Wagner, D. A., Glogowski, J., Skipper, P. L., Wishnok, J. S., and Tannenbaum, S. R., 1982, Analysis ofnitrate, nitrite, and [15N]nitrae in biologicalfluids. Anal.Biochem. 126:131–138.
Gyan, B., Troye-Blomberg, M., Perlmann, P., and Bjorkman, A., 1994, Human monocytes cultured with and withoutinterferon-gamma inhibit Plasmodium falciparum parasite growth in vitro via secretion of reactive nitrogen intermediates, Parasite Immunol. 16:371–375.
Haddad, I. Y., Pataki, G., Hu, P., Galliani, C., Beckman, J. S., and Matalon, S., 1994, Quantitation of nitrotyrosine levels in lung sections of patients and animals with acute lung injury, J. Clin. Invest. 94:2407–2413.
Harwix, S., Andreesen, R., Ferber, E., and Schwamberger, G., 1992, Human macrophagessecrete a ftumoricidal activity distinct from tumour necrosis factor-α and reactive nitrogen intermediates, Res. Immunol. 143:89–94.
Hibbs, J. B., Jr., Westenfelder, C., Taintor, R., Vavrin, Z., Kablitz, C., Baranowski, R. L., Ward, J. H., Menlove, R. L., McMurry, M. P., Kushner, J. P., and Samlowski, W. E., 1992, Evidence for cytokine-inducible nitric oxide synthesis from L-arginine in patients receiving interleukin-2 therapy, J. Clin. Invest. 89:867–877.
Hooper, D. C., Bagasra, O., Marini, J. C., Zborek, A., Ohnishi, S. T., Kean, R., Champion, J. M., Sarker, A. B., Bobroski, L., Farber, J. L., Akaike, T., Maeda, H., and Koprowski, H., 1997, Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxynitrite: Implications for the treatment of multiple sclerosis, Proc. Natl. Acad. Sci. USA 94:2528–2533.
Hunt, N. C., and Goldin, R. D., 1992, Nitric oxide production by monocytes in alcoholic liver disease, J. Hepatol. 14:146–150.
Ikeda, I., Kasajima, T., Ishiyama, S., Shimojo, T., Takeo, Y., Nishikawa, T., Kameoka, S., Hiroe, M., and Mitsunaga, A., 1997, Distribution of inducible nitric oxide synthase in ulcerative colitis, Am. J. Gastroenterol. 92:1339–1341.
Kashem, A., Endoh, M., Yano, N., Yamauchi, F., Nomoto, Y., and Sakai, H., 1996, Expression of inducible-NOS in human glomerulonephritis—The possible source is infiltrating monocytes/ macrophages, Kidney Int. 50:392–399.
Kawase, T., Oguro, A., Orikasa, M., and Burns, D. M., 1996, Characteristics of NaF-induced differentiation of HL-60 cells, J. Bone Miner. Res. 11:1676–1687.
Keller, R., Keist, R., Joller, P., and Groscurth, P., 1993, Mononuclear phagocytes from human bone marrow progenitor cells; morphology, surface phenotype, and functional properties and activated cells, Clin. Exp. Immunol. 91:176–182.
Kim, C., Schinkel, C., Fuchs, D., Stadler, J., Walz, A., Zedler, S., von Donnersmarck, G. H., and Faist, E., 1995, Interleukin-13 effectively down-regulates the monocyte inflammatory potential during traumatic stress, Arch. Surg. 130:1330–1336.
King, J. M., Srivastava, K. D., Stefano, G. B., Bilfinger, T. V., Bahou, W. F., and Magazine, H. I., 1997, Human monocyte adhesion is modulated by endothelin B receptor-coupled nitric oxide release, J. Immunol. 158:880–886.
Kobzik, L., Bredt, D. S., Lowenstein, C. J., Drazen, J., Gaston, B., Sugarbaker, D., and Stamler, J. S., 1993, Nitric oxide synthase in human and rat lung: Immunocytochemical and histochemical localization, Am. J. Respir. Cell. Mol. Biol. 9:371–377.
Koeffler, H. P., 1986, Human acute myeloid leukemia lines: Models of leukemogenesis, Semin. Hematol. 23:223–236.
Kolb, J. P., Paul-Eugene, N., Damais, C., Yamaoka, K., Drapier, J.-C., and Dugas, B., 1994, Interleukin-4 stimulates cGMP production by IFN-γ-activated human monocytes. Involvement of the nitric oxide synthase pathway, J. Biol. Chem. 269:9811–9816.
Kooy, N. W., Royall, J. A., Ye, Y. Z., Kelly, D. R., and Beckman, J. S., 1995, Evidence for in vivo peroxynitrite production in human acute lung injury, Am. J. Respir. Crit. Care Med. 151:1250–1254.
Kumar, V., Jindal, S. K., and Ganguly, N. K., 1995, Release of reactive oxygen and n’itrogen intermediates from monocytes of patients with pulmonary tuberculosis, Scand. J. Clin. Lab Invest. 55:163–169.
Laffi, G., Foschi, M., Masini, E., Simoni, A., Mugnai, L., Lavilla, G., Barletta, G., Mannaioni, P. F., and Gentilini, P., 1995, Increased production of nitric oxide by neutrophils and monocytes from cirrhotic patients with ascites and hyperdynamic circulation, Hepatology 22:1666–1673.
Lafond-Walker, A., Chen, C. L., Augustine, S., Wu, T. C., Hruban, R. H., and Lowenstein, C. J., 1997, Inducible nitric oxide synthase expression in coronary arteries of transplanted human hearts with accelerated graft arteriosclerosis, Am. J. Pathol. 151:919–925.
Lammas, D. A., Stober, C., Harvey, C. J., Kendrick, N., Panchalingam, S., and Kumararatne, D. S., 1997, ATP-induced killing of mycobacteria by human macrophages is mediated by purinergic P2Z(p2X7) receptors, Immunity 7:433–444.
Lecoanet-Henchoz, S., Gauchat, J. F., Aubry, J. P., Graber, P., Life, P., Paul-Eugene, N., Ferrua, B., Corbi, A. L., Dugas, B., Platerzyberk, C., and Bonnefoy, J. Y., 1995, CD23 regulates monocyte activation through a novel interaction with the adhesion molecules CD11b-Cd18 and CD11c-CD18, Immunity 3:119–125.
Leibovich, S. J., Polverini, P. J., Fong, T. W., Harlow, L. A., and Koch, A. E., 1994, Production of angiogenic activity by human monocytes requires an L-arginine/nitric oxide-synthase-dependent effector mechanism, Proc. Natl. Acad. Sci. USA 91:4190–4194.
Liu, J., Zhao, M. L., Brosnan, C. F., and Lee, S. C., 1996, Expression of type II nitric oxide synthase in primary human astrocyte and microglie: role of IL-1 beta and IL-1 receptor antagonist, J. Immunol. 157:3569–3576.
Lopez-Guerrero, J. A., and Alonso, M. A., 1997, Nitric oxide production induced by herpes simplex virus type 1 does not alter the course of the infection in human monocytic cells, J. Gen. Virol. 78:1977–1980.
Lopez-Guerrero, J. A., Rayet, B., Tuynder, M., Rommelaere, J., and Dinsart, C., 1997, Constitutive activation of U937 promonocytic cell clones selected for their resistance to parvovirus H-l infection, Blood 89:1642–1653.
L’opez-Moratalla, N., Calleja, A., Gonzalez, A., Perez-Mediavilla, L. A., Aymerich, M. S., Burrel, M. A., and Santiago, E., 1996, Inducible nitric oxide synthase in monocytes from patients with Graves’ disease, Biochem. Biophys. Res. Commun. 226:723–729.
Luoma, J. S., Stralin, P., Marklund, S. L., Hiltunen, T. P., Sarkioja, T., and Ylaherttuala, S., 1998, Expression of extracellular SOD and NOS2 in macrophages and smooth muscle cells in human and rabbit atherosclerotic lesions—Colocalization with epitopes characteristic of oxidized LDL and peroxynitrite-modified proteins, Arterio. Thromb. Vasc. Biol. 18:157–167.
MacMicking, J., Xie, Q. W., and Nathan, C., 1997, Nitric oxide and macrophage function, Annu. Rev. Immunol. 15:323–350.
Magazine, H. I., Liu, Y., Bilfinger, T. V., Fricchione, G. L., and Stefano, G. B., 1996, Morphine-induced conformational changes in human monocytes, granulocytes, and endothelial cells and in inverte-brate immunocytes and microglia are mediated by nitric oxide, J. Immunol. 156:4845–4850.
Majano, P.L., Garcia-Monz’n, C., L’opez-Cabrera, M., Lara-Pezzi, E., Fern’andez-Ruiz, E., Garcia-Iglesias, C., Borque, M. J., and Moreno-Otero, R., 1998, Inducible nitric oxide synthase expression in chronic viral hepatitis. Evidence for a virus-induced gene upregulation, J. Clin. Invest. 101:1343–1352.
Malinski, T., Radomski, M. W., Taha, Z., and Moncada, S., 1993, Direct electrochemical measurement of nitric oxide released from human platelets, Biochem. Biophys. Res. Commun. 194:960–965.
Mannick, E. E., Bravo, L. E., Zarama, G., Realpe, J. L., Zhang, X. J., Ruiz, B., Fortham, E. T., Mera, R., Miller, M. J., and Correa, P., 1996, Inducible nitric oxide synthase, nitrotyrosine, and apoptosis, in Helicobacter pylori gastritis: effects of antibiotics and antioxidants, Cancer Res. 56:3238–3243.
Mannick, J. B., Asano, K., Izumi, K., Kieff, E., and Stamler J. S., 1994, Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation, Cell 79:1137–1146.
Mannick, J. B., Miao, X. Q., and Stamler, J. S., 1997, Nitric oxide inhibits Fas-induced apoptosis, J. Biol. Chem. 272:24125–24128.
Martin, J. H., and Edwards, S. W., 1993, Changes in mechanisms of monocyte/macrophage-mediated cytotoxicity during culture. Reactive oxygen intermediates are involved in monocyte-mediated cytotoxicity, whereas reactive nitrogen intermediates are employed by macrophages in tumor cell killing, J. Immunol. 150:3478–3486.
Martin, J. H., and Edwards, S. W., 1994. Interferon-gamma enhances monocyte cytotoxicity via enhanced reactive oxygen intermediate production. Absence of an effect on macrophage cytotoxicity is due to failure to enhance reactive nitrogen intermediate production. Immunology 81:592–597.
Masini, E., Mugnai, L., Foschi, M., Laffi, G., Gentilini, P., and Mannaioni, R. F., 1995, Changes in the production of nitric oxide and superoxidc by inflammatory cells in liver cirrhosis, Int. Arch. Allergy Immunol. 107:197–198.
Mautino, G., Paul-Eugene, N., Chanez, P., Vignola, A. M., Kolb, J. P., Bousquet, J., and Dugas, B., 1994, Heterogeneous spontaneous and interleukin-4-induced nitric oxide production by human monocytes, J. Leukoc. Biol. 56:15–20.
McDermott, C. D., Gavita, S. M., Shennib, H., and Giaid, A., 1997, Immunohistochemical localization of nitric oxide synthase and the oxidant peroxynitrite in lung transplant recipients with obliterative bronchiolitis, Transplantation 64:270–274.
McInnes, I. B., Leung, B. P., Field, M., Wei, X. Q., Huang, F.-P., Sturrock, R. D., Kinninmonth, A., Weidner, J., Mumford, R., and Liew, F. Y., 1996, Production of nitric oxide in the synovial membrane of rheumatoid and osteoarthritis patients, J. Exp. Med. 184:1519–1524.
McLachlan, J. A., Serkin, C. D., and Bakouche, O., 1996, Dehydroepiandrosterone modulation of lipopolysaccharide-stimulated monocyte cytotoxicity, J. Immunol. 156:328–335.
Michel, T., and Feron, O., 1997, Nitric oxide synthases—Which, where, how, and why, J. Clin. Invest. 100:2146–2152.
Middleton, S. J., Cuthbert, A. W., Shorthouse, M., and Hunter, J. O., 1993a, Nitric oxide affects mammalian distal colonic smooth muscle by tonic neural inhibition, Br. J. Pharmacol. 108:974–979.
Middleton, S. J., Shorthouse, M., and Hunter, J. O., 1993b, Relaxation of distal colonic circular smooth muscle by nitric oxide derived from human leucocytes, Gut 34:814–817.
Moilanen, E., Moilanen, T., Knowles, R., Charles, I., Kadoya, Y., al-Saffar, N., Revell, P. A., and Moncada, S., 1997, Nitric oxide synthase is expressed in human macrophages during foreign body inflammation. Am. J. Pathol. 150:881–887.
Moncada, S., and Higgs, A., 1993, The L-arginine-nitric oxide pathway, N.Engl. J. Med. 329:2002–2012.
Muõz-Fernãndez, M. A., Fernãndez, M. A., and Fresno, M., 1992, Activation of human macrophages for the killing of intracellular Trypanosoma cruzi by TNF-alpha and IFN-gamma through a nitric oxide-dependent mechanism, Immunol. Lett. 33:35–40.
Murray, H. W., and Teitelbaum, R. F., 1992, L-Arginine-dependent reactive nitrogen intermediates and the antimicrobial effect of activated human mononuclear phagocytes, J. Infect. Dis. 165:513–517.
Myatt, L., Eis, A. L. W., Brockman, D. E., Kossenjans, W., Greer, I., and Lyall, F., 1997, Inducible (type II) nitric oxide synthase in human placental villous tissue of normotensive, pre-eclamptic and intrauterine growth-restricted pregnancies, Placenta 18:261–268.
Naotunne, T. S., Karunaweera, N. D., Mendis, K. N., and Carter, R., 1993, Cytokine-mediated inactivationof malarial gametocytes is dependent on the presence of white blood cells and involves reactive nitrogen intermediates, Immunology 78:555–562.
Nathan, C. and Xie, Q.-W., 1994, Regulation ofbiosynthesis of nitric oxide, J. Biol. Chem. 269:13725–13728.
Nicholson, S., Bonecini-Almeida, M. D. G., Silva, L. E., Jr., Nathan, C., Xie, Q.-W., Mumford, R., Weidner, J. R., Calaycay, J., Geng, J., Boechat, N., Linhares, C., Rom, W., and Ho, J. L., 1996, Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tubercu-losis, J. Exp. Med. 183:2293–2302.
Nozaki, Y., Hasegawa, Y., Ichiyama, S., Nakashima, I., and Shimokata, K., 1997, Mechanism of nitric oxide-dependent killing of Mycobacterium bovis BCG in human alveolar macrophages, Infect. Immun. 65:3644–3647.
Ochoa, J. B., Udekwu, A. O., Billiar, T. R., Curran, R. D., Cerra, F. B., Simmons, R. L., and Peitzman, A. B., 1991, Nitrogen oxide levels in patients after trauma and during sepsis, Ann. Surg. 214:621–626.
Ochoa, J. B., Curti, B., Peitzman, A. B., Simmons, R. L., Billiar, T. R., Hoffman, R., Rault, R., Longo, D. L., Urba, W. J., and Ochoa, A. C., 1992, Increased circulating nitrogen oxides after human tumor immunotherapy: Correlation with toxic hemodynamic changes, J. Natl. Cancer Inst. 84:864–867.
Padgett, E. L., and Pruett, S. B., 1992, Evaluation of nitrite production by human monocyte-derived macrophages, Biochem. Biophys. Res. Commun. 286:775–781.
Paul-Eugene, N., Kolb, J. P., Damais, C., Yamaoka, K., and Dugas, B., 1994, Regulatory role of nitric oxide in the IL-4-induced IgE production by normal human peripheral blood mononuclear cells. Lymphokine Cytokine Res. 13:287–293.
Paul-Eugene, N., Kolb, J. P., Sarfati, M., Arock, M., Ouaaz, F., Debre, P., Mossalayi, D. M., and Dugas, B., 1995a, Ligation of CD23 activates soluble guanylate cyclase in human monocytes via an L-arginine-dependent mechanism, J. Leukoc. Biol. 57:160–167.
Paul-Eugene, N., Mossalayi, D., Sarfati, M., Yamaoka, K., Aubry, J. P., Bonnefoy, J. Y., Dugas, B., and Kolb, J. P., 1995b, Evidence for a role of Fc epsilon RII/CD23 in the IL-4-induced nitric oxide production by normal human mononuclear phagocytes, Cell. Immunol. 163:314–318.
Paul-Eugene, N., Pene, J., Bousquet, J.,and Dugas, B., 1995c, Role of cyclic nucleotides and nitric oxide in blood mononuclear cell IgE production stimulated by IL-4, Cytokine 7:64–69.
Perez-Mediavilla, L. A., Lopez-Zabalza, M. J., Calonge, M., Montuenga, L., L’opez-Moratalla, N., and Santiago, E., 1995, Inducible nitric oxide synthase in human lymphomononuclear cells activated by synthetic peptides derived from extracellular matrix proteins, FEBS Lett. 357:121–124.
Perez-Perez, G. I., Shepherd, V. L., Morrow, J. D., and Blaser, M. J.,1995, Activation ofhuman THP-1 cells and rat bone marrow-derived macrophages by Helicobacter pylori lipopolysaccharide, Infect. Immun. 63:1183–1187.
Perkins, D. J., St. Clair, W. E., Misukonis, M. A., and Weinberg, J. B., 1998, Reduction of NOS2 overexpression in rheumatoid arthritis patients treated with anti-TNF-alpha monoclonal antibody (cA2), Arth. Rheum. 41:2205–2210.
Petit, J. F., Phan-Bich, L., Lemaire, G., Martinache, C., and Lopez, M., 1993, During their differentia-tion into macrophages, human monocytes acquire cytostatic activity independent of NO and TNF alpha, Res. Immunol. 144:277–280.
Pietraforte, D., Tritarelli, E., Testa, U., and Minetti, M., 1994, Gpl20 HIV envelope glycoprotein increases the production ofnitric oxide in human monocyte-derived macrophages, J. Leukoc. Biol. 55:175–182.
Polack, B., Pernod, G., Barro, C., and Doussiere, J., 1997, Role of oxygen radicals in tissue factor induction by endotoxin in blood monocytes, Haemostasis 27:193–200.
Radomski, M.W., Palmer, R.M., and Moncada, S., 1990, Characterization of the L-arginine:nitric oxide pathway in human platelets, Br. J. Pharmacol. 101:325–328.
Rajora, N., Ceriani, G., Catania, A., Star, R. A., Murphy, M. T., and Lipton, J. M., 1996, Alpha-MSH production, receptors, and influence on neopterin in a human monocyte/macrophage cell line, J. Leukoc. Biol. 59:248–253.
Reiling, N., Ulmer, A. J., Duchrow, M., Ernst, M., Flad, H.-D., and Hauschildt, S., 1994, Nitric oxide synthase: mRNA expression of different isoforms in human monocytes/macrophages, Eur. J. Immunol. 24:1941–1944.
Reiling, N., Kroncke, R., Ulmer, A. J., Gerdes, J., Flad, H.-D., and Hauschildt, S., 1996, Nitric oxide synthase-Expression of the endothelial, Ca2+/calmodulin-dependent in human B and T lymphocytes, Eur. J. Immunol. 26:511–516.
Roman, V., Dugas, N., Abadie, A., Amirand, C., Zhao, H., Dugas, B., and Kolb, J. P., 1997, Characterization of a constitutive type III nitric oxide synthase in human U937 monocytic cells-Stimulation by soluble CD23, Immunology 91:643–648.
Saha, D.C., Astiz, M.E., Lin, R.Y., Rackow, E.C., and Eales, L.J., 1997, Monophosphoryl lipid A stimulated up-regulation of nitric oxide synthase and nitric oxide release by human monocytes in vitro, Immunopharmacology 37:175–184.
Sakai, N., and Milstien, S., 1993, Availability of tetrahydrobiopterin is not a factor in the inability to detect nitric oxide production by human macrophages, Biochem. Biophys. Res. Commun. 193:378–383.
Sakurai, H., Kohsaka, H., Liu, M. F., Higashiyama, H., Hirata, Y., Kanno, K., Saito, I., and Miyasaka, N., 1995, Nitric oxide production and inducible nitric oxide synthase expression in inflammatory arthritides, J. Clin. Invest. 96:2357–2363.
Salvemini, D., de Nucci, G., Gryglewski, R. J., and Vane, J. R., 1989, Human neutrophils and mononuclear cells inhibit platelet aggregation by releasing a nitric oxide-like factor, Proc. Natl. Acad. Sci. USA 86:6328–6332.
Schmidt, H. H. H. W., Seifert, R., and Böhme, E., 1989, Formation and release of nitric oxide from human neutrophils and HL-60 cells induced by a chemotactic peptide, platelet activating factor and leukotriene B4, FEBS Lett. 244:357–360.
Schneemann, M., Schoedon, G., Hofer, S., Blau, N., Guerrero, L., and Schaffner, A., 1993, Nitric oxide synthase is not a constituent of the antimicrobial armature of human mononuclear phagocytes, J. Infect. Dis. 167:1358–1363.
Schneemann, M., Schoedon, G., Linscheid, P., Walter, R., Blau, N., and Schaffner, A., 1997, Nitrite generation in interleukin-4-treated human macrophage cultures does not involve the nitric oxide synthase pathway, J. Infect. Dis. 175:130–135.
Seitzer, U., Scheeltoellner, D., Toellner, K. M., Reiling, N., Haas, H., Galle, J., Flad, H.-D., and Gerdes, J., 1997, Properties of multinucleated giant cellsina new in vitro model for human granuloma formation, J. Pathol. 182:99–105.
Sharara, A. I., Perkins, D. J., Misukonis, M. A., Chan, S. U., Dominitz, J. A., and Weinberg, J. B., 1997, Interferon-alpha activation of human mononuclear cells in vitro andinvivofornitricoxide synthase type 2 mRNA and protein expression. Possible relationship of induced NOS2 to the anti-hepatitis C effects of IFN-ga in vivo, J. Exp. Med. 186:1495–1502.
Sherman, M. P., Loro, M. L., Wong, V. Z., and Tashkin, D. P., 1991, Cytokine-and Pneumocystis carinii-induced L-arginine oxidation by murine and human pulmonary alveolar macrophages, J. Protozool. 38:234S–236S.
Siedlar, M., Marcinkiewicz, J., and Zembala, M., 1995, MHC class I and class II determinants and some adhesion molecules are engaged in the regulation of nitric oxide production in vitro by human monocytes stimulated with colon carcinoma cells, Clin. Immunol. Immunopathol. 77:380–384.
Singer, I. I., Kawka, D. W., Scott, S., Weidner, J. R., Mumford, R. A., Riehl, T. E., and Stenson, W. F., 1996, Expression of inducible nitric oxide synthase and nitrotyrosine in colonic epithelium in inflammatory bowel disease, Gastroenterology 111:871–885.
Snell, J. C., Chernyshev, O., Gilbert, D. L., and Colton, C. A., 1997, Polyribonucleotides induce nitric oxide production by human monocyte-derived macrophages, J. Leukoc. Biol. 62:369–373.
Stamler, J. S., Singel, D. J., and Loscalzo, J., 1992, Biochemistry of nitric oxide and its redox-activated forms, Science 258:1898–1902.
St. Clair, E. W., Wilkinson, W. E., Lang, T., Sanders, L., Misukonis, M. A., Gilkeson, G. S., Pisetsky, D. S., Granger, D. L., and Weinberg, J. B., 1996, Increased expression of blood mononuclear cell nitric oxide synthase type 2 in rheumatoid arthritis patients, J. Exp. Med. 184:1173–1178.
Stefano, G. B., Liu, Y., and Goligorsky, M. S., 1996, Cannabinoid receptors are coupled to nitric oxide release in invertebrate immunocytes, microglia, and human monocytes, J. Biol. Chem. 271:19238–19242.
Steube, K. G., Teepe, D., Meyer, C., Zaborski, M., and Drexler, H. G., 1997, A model system in haematology and immunology—The human monocytic cell line Mono-Mac-1, Leuk. Res. 21:327–335.
Summersgill, J. T., Powell, L. A., Buster, B. L., Miller, R. D., and Ramirez, J. A., 1992, Killing of Legionella pneumophila by nitric oxide in gamma-interferon-activated macrophages, J. Leukoc. Biol. 52:625–629.
ter Steege, J., Buurman, W., Arends, J. W., and Forget, P., 1997, Presence of inducible nitric oxide synthase, nitrotyrosine, CD68, and CD14 in the small intestine in celiac disease, Lab. Invest. 77:29–36.
Thomsen, L. L., Lawton, F. G., Knowles, R. G., Beesley, J. E., Riveros-Moreno, V., and Moncado, S., 1994, Nitric oxide synthase in human gynecological cancer, Cancer Res. 54:1352–1354.
Thomsen, L. L., Miles, D. W., Happerfield, L., Bobrow, L. G., Knowles, R. G., and Moncada, S., 1995, Nitric oxide synthase activity in human breast cancer, Br. J. Cancer 72:41–44.
Tracey, W. R., Xue, C., Klinghofer, V., Barlow, J., Pollock, J. S., Forstermann, U., and Johns, R. A., 1994, Immunochemical detection of inducible NO synthase in human lung, Am. J. Physiol. 266:L722–L727.
Tufano, M. A., Rossano, F., Catalanotti, P., Liguori, G., Marinelli, A., Baroni, A., and Marinelli, P., 1994, Properties of Yersinia enterocolitica porins: Interference with biological functions of phagocytes, nitric oxide production and selective cytokine release, Res. Microbiol. 145:297–307.
Vial, T., and Descotes, J., 1995, Immune-mediated side-effects of cytokines in humans, Toxicology 105:31–57.
Vitek, M. P., Snell, J., Dawson, H., and Colton, C. A., 1997, Modulation of nitric oxide production in human macrophages by apolipoprotein-E and amyloid-beta peptide, Biochem. Biophys. Res. Commun. 240:391–394.
Vouldoukis, I., Riverosmoreno, V., Dugas, B., Ouaaz, F., Becherel, P., Debre, P., Moncada, S., and Mossalayi, M. D., 1995, The killing of Leishmania major by human macrophages is mediated by nitric oxide induced after ligation of the Fc-epsilon-RII/CD23 surface antigen, Proc. Natl. Acad. Sci. USA 92:7804–7808.
Vouldoukis, I., Becherel, P. A., Riverosmoreno, V., Arock, M., Dasilva, O., Debre, P., Maizer, D., and Mossalayi, M. D., 1997, Interleukin-10 and interleukin-4 inhibit intracellular killing of Leishmania infantum and Leishmania major by human macrophages by decreasing nitric oxide generation, Eur. J. Immunol. 27:860–865.
Wang, C. L., Su, M. H., Chao, T. Y., Shaio, M. F., and Yang, K. D., 1996, When do human macrophages release nitric oxide? Variable effects of certain in vitro cultural and in vivo resident conditions, Proc. Natl. Sci. Counc. Repub. China B 20:65–70.
Watkins, S. C., Macaulay, W., Turner, D., Kang, R., Rubash, H. E., and Evans, C. H., 1997, Identification of inducible nitric oxidesynthase in human macrophages surrounding loosened hip prostheses. Am. J. Pathol. 150:1199–1206.
Weinberg, J. B., Misukonis, M. A., Shami, P. J., Mason, S. N., Sauls, D. L., Dittman, W. A., Wood, E. R., Smith, G. K., McDonald, B., Bachus, K. E., Haney, A. F., and Granger, D. L., 1995, Human mononuclear phagocyte inducible nitric oxide synthase (NOS2). Analysis of NOS2 mRNA, NOS2 protein, biopterin, and nitric oxide production by blood monocytes and peritoneal macrophages, Blood 86:1184–1195.
Weyand, C. M., Wagner, A. D., Bjornsson, J., and Goronzy J. J., 1996, Correlation of the topographical arrangement and the functional pattern of tissue-infiltrating macrophages in giant cell arteritis, J. Clin.Invest. 98:1642–1649.
Wickramasinghe, S. N., and Hasan, R., 1993, Possible role of macrophages in the pathogenesis of ethanol-induced bone marrow damage, Br. J. Haematol. 83:574–579.
Wilcox, J. N., Subramanian, R. R., Sundell, C. L., Tracey, W. R., Pollock, J. S., Harrison, D. G., and Marsden, P. A., 1997, Expression of multiple isoforms of nitric oxide synthase in normal and atherosclerotic vessels, Arterio. Thromb. Vasc. Biol. 17:2479–2488.
Wildhirt, S. M., Dudek, R. R., Suzuki, H., and Bing, R. J., 1995, Involvement of inducible nitric oxide synthase in the inflammatory process of myocardial infarction, Int. J. Cardiol 50:253–261.
Zarlingo, T. J., Eis, A.L. W., Brockman, D. E., Kossenjans, W., and Myatt, L., 1997, Comparative localisation of endothelial and inducible nitric oxide synthase isoforms in haemochorial and epitheliochorial placentae, Placenta 18:511–520.
Zembala, M., Siedlar, M., Marcinkiewicz, J., and Pryjma, J., 1994, Human monocytes are stimulated for nitric oxide release in vitro by some tumor cells but not by cytokines and lipopolysaccharide, Eur. J. Immunol. 24:435–439.
Zhou, A. Q., Chen, Z. F., Rummage, J. A., Jiang, H., Kolosov, M., Kolosova, I., Stewart, C. A., and Leu, R. W., 1995, Exogenous interferon-gamma induces endogenous synthesis of interferon-alpha and-beta by murine macrophages for induction of nitric oxide synthase, J. Interferon Cytokine Res. 15:897–904.
Zinetti, M., Fantuzzi, G., Delgado, R., Di Santo, E., Ghezzi, P., and Fratelli, M., 1995, Endogenous nitric oxide production by human monocytic cells regulates EPS-induced TNF production, Eur. Cytokine Network 6:45–48.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Kluwer Academic Publishers
About this chapter
Cite this chapter
Weinberg, J.B. (2002). Human Mononuclear Phagocyte Nitric Oxide Production and Inducible Nitric Oxide Synthase Expression. In: Fang, F.C. (eds) Nitric Oxide and Infection. Springer, Boston, MA. https://doi.org/10.1007/0-306-46816-6_6
Download citation
DOI: https://doi.org/10.1007/0-306-46816-6_6
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-46147-7
Online ISBN: 978-0-306-46816-2
eBook Packages: Springer Book Archive